Hauterive, Neuchatel, 20 December 2018 – G-ray Switzerland and CSEM have achieved a major milestone in packaging the latenium™ technology to deliver X-ray imaging solutions: the latenium™ Evaluation Kit. Centered on particle-counting X-ray imaging, these unique solutions are set to improve the quality of the images obtained from examinations such as breast cancer screening helping earlier detection and reducing the radiation doses currently needed for mammography. “This milestone enables us to demonstrate the huge potential of our latenium™ detectors with our first high resolution images,” emphasizes Philippe Le Corre, CEO of G-ray Medical

G-ray Switzerland SA, a Neuchâtel start-up, is currently developing ultra-high performance detectors dedicated to medical applications (in particular mammography). These ultra-high performance detectors will be developed in partnership with CSEM, based on G-ray’s revolutionary lateniumTM technology.

“The main challenge is now miniaturising both the sensor’s pixels and the system’s energy consumption, whilst offering very high-quality X-ray imaging for new generations of medical imaging solutions,” explains Mario El-Khoury, CEO at CSEM.

Since the beginning of the 21st century, there has been a worrying increase in cases of breast cancer among young women. To maximise the chances of recovery of this frequent cancer, an early and reliable diagnosis of the disease is crucial. G-Ray Medical intends to offer the medical world a new generation of X-ray imagers based on its lateniumTM electronic technology. A specific development is on-going with CSEM G-ray to produce the first lateniumTM-based medical detector, planned to be completed by end of 2019.

Click here to read the full version of this press release.

For additional information please contact:

G-ray Medical Sàrl
Philippe Le Corre
CEO
Mobile: +41 79 171 71 30
E-mail: philippe.le.corre@g-ray.ch

About G-ray Switzerland

G-ray Switzerland SA is a development stage company, based in the State of Neuchâtel, Switzerland, created in November 2014, with validated core competences in monolithic CMOS integrated pixel array detector technology, applicable to a wide range of fields including Medical Imaging, Microelectromechanical Systems, High Energy Physics, Aerospace, and Security.